A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled
NCT02044419
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
lomitapide
Sponsor
Aegerion Pharmaceuticals, Inc.